Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Letters to the Editor

Staff  |  Issue: July 2007  |  July 1, 2007

In May’s “Rheuminations” column (“Make Peace with Complexity,” p. 6), we asked how you would manage gout in a patient with multiple comorbidities and complications. (See the full description at right.) We received an overwhelming number of letters recommending a range of treatment approaches. We’ve published a selection of those responses here, and we want to thank everyone who wrote in. Keep those letters coming!

—The Editors

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Patient

  • Seventy-two-year-old man with heart failure;
  • Taking oxygen, furosemide, and coumadin;
  • Ejection fraction of 20, creatinine of 2.5, blood urea nitrogen of 60, INR near 3; and
  • Fever and an infiltrate on chest X-ray that could be pneumonia, atelectasis, or pulmonary congestion.

Readers’ Treatment Strategies

Tylenol #3. Actually, I would consider a steroid taper, also, since the immunosuppression issue is probably overstated.

J. Stephen Thompson, MD, Rheumatologist

Arthritis Center of the Rockies, Loveland, Colo.

 

No non-steroidal anti-inflammatory drugs (NSAIDs) or colchicine. Ice works well for pain—so do narcotics, though with his respiratory status, I’m not so keen on them. I favor an intra-arterial steroid. If you’re nervous about causing a hemarthrosis, perhaps give it under ultrasound guidance. I’ve never had a problem with intra-articular bleeding in patients on warfarin with either joint injection or aspiration.

My counter-case to yours was a file I was asked to review as a medicolegal expert: A young man with congenital heart disease on warfarin went to the emergency room with one swollen, painful joint. Aspiration was not done because he is on warfarin. Instead the doctor stopped the drug, thinking he had a hemarthrosis. While off warfarin, he stroked out from a cardiac embolus. Later he had recurrent acute monoarthritis that turned out to be gout! The emergency room doctors were sued.

My literature review for that indicated that most who considered the matter felt it was safe to aspirate or inject a joint even in an anti-coagulated patient. Some suggested a smaller caliber needle as a precaution and increased pressure on the site after.

Philip Baer, MDCM, Rheumatologist

Malvern Medical Arts Centre, Toronto, Ontario

 

What I would do for the patient, in order of preference:

  1. Intra-articular steroids (as long as I felt the knee was not infected);
  2. Adrenocorticotropic hormone (ACTH); or
  3. Systemic corticosteroids if the patient is adequately covered for infection with antibiotics, but I would try a low to moderate dose (20 mg to start with rapid taper). This option is not very good, not only because of infection concerns but also because it could cause fluid retention.

Bonita Libman, MD, Associate Professor of Medicine

University of Vermont, Burlington

 

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:GoutQualityTreatment

Related Articles

    Colchicine: An Ancient Drug with Modern Uses

    August 11, 2021

    Discovered more than 3,000 years ago, colchicine is one of the oldest drugs still in use today. Like most old remedies, colchicine is a chemical substance found in many plants, most notably in colchicum autumnale, known as wild saffron or autumn crocus. It was mentioned in the oldest Egyptian medical text, Ebers Papyrus (circa 1550…

    Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium

    April 2, 2014

    Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered

    Case Report: Warfarin-Induced Non-Uremic Calciphylaxis Mimicking Vasculitis

    May 13, 2021

    Calciphylaxis, or calcific uremic arteriolopathy, is a rare disease characterized by calcification of the arterioles and capillaries in the dermis and subcutaneous tissue, resulting in thrombus formation and subsequent skin ischemia and necrosis.1 This serious condition most commonly occurs in patients with end-stage renal disease (ESRD) requiring dialysis or in kidney transplant recipients. In rare…

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences